1. Opening Hook
When your quarterly report reads like a weather forecast, you know the monsoon’s now on the audit committee. 🌧️ Dhanuka blamed both excess and missing rains — a first for corporate versatility. Yet, even the clouds couldn’t dampen their optimism: Dahej is brewing new molecules, and Nippon Soda’s partnership brings some imported chemistry to desi soil.
As the Bhagavad Gita reminds us — “You have the right to perform your duty, but not to the fruits of action.”
Read on — because the fruits (and margins) get juicier later.
2. At a Glance
- Revenue down 9% – Even the rain gods took a commission this time.
- EBITDA ₹136.7 Cr (↓14%) – The fertilizer didn’t reach EBITDA either.
- PAT ₹93.9 Cr (↓20%) – Profits washed away faster than pests in heavy rain.
- Royalty income ₹4.5 Cr – Courtesy of Bayer, but no fireworks yet.
- Stock flat – Investors also stuck in kharif-rabi confusion.
3. Management’s Key Commentary
M.K. Dhanuka: “Uneven rainfall impacted agrochemical demand.”
(Translation: Nature cut 9% off our topline, no Excel error here.)
Harsh Dhanuka: “Trial production of Difenoconazole has begun at Dahej.”
(Translation: The lab is cooking, just don’t ask when the revenue gets served.)
Rahul Dhanuka: “Farmers didn’t shift to generics, they just didn’t spray anything.”
(Translation: Even weeds got a monsoon break 😏.)
Vinod Bansal (CFO): “Dahej sales ₹22 Cr, with a nominal loss of ₹46 lakh.”
(Translation: ‘Nominal loss’ = CFO’s polite word for bleeding cash.)
Harsh Dhanuka: “Bayer revenue will be lower this year; royalties up.”
(Translation:
